FairJourney Biologics is an established company with an outstanding track record of biotech and biopharmaceutical partners, which offers a range of assets and services on antibody engineering, discovery and production.
Our naïve and immune libraries from humans, rodents and llama together with our know-how with immunization and panning protocols allow us to contribute to the pipeline of our partners on complex targets.
FairJourney Biologics and IONTAS combined capabilities in 2020 as a fee for service antibody discovery company. The combined operations allow a complete offering around antibody discovery. Using fully validated naïve libraries with parallel immune approaches and the unrivalled mammalian display technology to optimise antibody discovery research. The team of more than 100 scientists, anchored in a high-profile network of advisors, has successfully completed more than 150 projects, with over 50 biotechnology and pharmaceutical companies.
Location: Portugal, Porto
Member count: 51-200
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | GHO Capita... | ghocapital... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 17.09.2021 | FairJourne... | FairJourney Biologics announce... | - | - | cambridgen... |
| 01.09.2021 | FairJourne... | FairJourney Biologics expands ... | - | - | cambridgen... |
| 01.07.2021 | FairJourne... | FairJourney Biologics introduc... | - | - | cambridgen... |
| 12.04.2021 | FairJourne... | FairJourney Biologics enters n... | - | - | cambridgen... |